Clinical Trials Sponsored by Acutus Medical

Total 55439 results

Acutus Medical

Not yet recruiting

AcQBlate Force Sensing Ablation System EU Study for Atrial Fibrillation (AcQForce AF-EU)

Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
Acutus Medical

Terminated

AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry) (DISCOVER)

Ablation of Arrhythmia's

United Kingdom, Germany, Netherlands, France
Acutus Medical

Withdrawn

AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation (AcQForce AF)

Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
Acutus Medical

Completed

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation (RECOVER AF)

Recurrent Atrial Fibrillation

United Kingdom, Netherlands, Germany, Canada, Czechia, Belgium
Acutus Medical

Completed

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER-AF)

Persistent Atrial Fibrillation

United Kingdom, Germany, Netherlands, Canada, Czechia, Italy
Acutus Medical

Completed

Dipole Density Mapping in Supraventricular Tachycardia (DDRAMATIC-SVT)

Supraventricular Tachycardia

United Kingdom, Canada, Czechia, Belgium, Chile, Germany
Acutus Medical

Withdrawn

Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia (DDRAMATIC-SVT)

Supraventricular Tachycardia

Ireland
Acutus Medical

Completed

AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) (AcQForce AFL)

Typical Atrial Flutter

Belgium, United States, United Kingdom
Acutus Medical

Completed

AcQBlate Force Sensing Ablation System EU Study for Atrial Flutter (AcQForce Flutter-EU) (AFL-EU)

Typical Atrial Flutter

Belgium, United Kingdom
Acutus Medical

Withdrawn

Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation (PLASZMA)

Atrial Arrhythmias
Acutus Medical

Withdrawn

AcQBlate Force Confirmatory Study for Atrial Arrhythmias

Atrial Arrhythmias

Czechia
Acutus Medical

Completed

Dipole Density Mapping of Typical Atrial Flutter (DDRAMATIC)

Atrial Flutter

Germany
Acutus Medical

Completed

AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study)

Catheter Ablation

United States
Acutus Medical

Terminated

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

Ablation of Arrhythmia's

United States
Acutus Medical

Completed

AcQForce Pulsed Field Ablation-CE (PFA-AF)

Atrial Fibrillation | Atrial Arrhythmia

Czechia
Acutus Medical

Completed

Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter (DDRAMATIC)

Atrial Flutter

Belgium
Royal Brompton & Harefield NHS Foundation Trust
Acutus Medical

Unknown

HCM-AF Ablation With ACUTUS

Atrial Fibrillation | Hypertrophic Cardiomyopathy
Acerus Biopharma Inc.

Terminated

Evaluation of Testosterone Nasal Gel in Hypogonadal Boys

Hypogonadism

United Kingdom
Autus Valve Technologies, Inc.

Recruiting

Autus Valve Pivotal Study

Congenital Heart Disease

United States
Cutis Medical Laser Clinics Pte Ltd

Not yet recruiting

Superficial MFU-V and Diluted Calcium Hydroxyapatite for the Improvement of Lower Face Skin Quality and Wrinkles

Aging

Singapore
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-I)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) (ARRECTOR)

Scalp Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Psoriasis | Plaque Psoriasis

United States, Canada, Dominican Republic
Arbutus Biopharma Corporation

Terminated

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

Chronic Hepatitis

Korea, Republic of, Hong Kong, Thailand, Canada, Australia, Moldova, Republic of, New Zealand, Ukraine
Arcutis Biotherapeutics, Inc.

Completed

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis (MUSE)

Plaque Psoriasis

United States
Acerus Pharmaceuticals Corporation

Completed

Efficacy and Tolerability of an Intra-Nasal Testosterone Product

Hypogonadism

United States
Acerus Pharmaceuticals Corporation

Completed

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Female Orgasmic Disorder

United States, Canada, Australia
Arbutus Biopharma Corporation

Completed

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

Hepatitis B, Chronic

Australia, New Zealand
Acerus Pharmaceuticals Corporation

Completed

NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers

Hypogonadism

United States
Arbutus Biopharma Corporation

Terminated

Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol

Hypercholesterolemia

United States
Arbutus Biopharma Corporation

Not yet recruiting

Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection

Hepatitis B, Chronic
Acerus Pharmaceuticals Corporation

Recruiting

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Hypogonadism

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

Chronic Hand Eczema

United States, Australia, Canada
Arbutus Biopharma Corporation

Active, not recruiting

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

Chronic Hepatitis b

United States, Korea, Republic of, Hong Kong, Taiwan, Australia, Moldova, Republic of, Ukraine
Arcutis Biotherapeutics, Inc.

Active, not recruiting

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-2)

Chronic Plaque Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis

Plaque Psoriasis

United States, Australia, Bulgaria, Canada
Arcutis Biotherapeutics, Inc.

Terminated

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Vitiligo

United States
Acerus Pharmaceuticals Corporation

Completed

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

Female Sexual Dysfunction

United States
Acerus Pharmaceuticals Corporation

Completed

Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ (MyT)

Hypogonadism

Canada
Arbutus Biopharma Corporation

Completed

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, Adult

United States, Taiwan, Singapore, China, Canada, Korea, Republic of
Acerus Pharmaceuticals Corporation

Completed

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Male Hypogonadism

United States
Acerus Pharmaceuticals Corporation

Completed

Efficacy of an Intranasal Testosterone Product

Hypogonadism

United States
Altus Pharmaceuticals

Unknown

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

Growth Hormone Deficiency

United States
Arbutus Biopharma Corporation

Not yet recruiting

Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

Long Term Follow-up

Hong Kong, Australia, Taiwan, United Kingdom
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)

Seborrheic Dermatitis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-OLE)

Chronic Plaque Psoriasis

United States, Canada, Dominican Republic

Clinical Trials Sponsored by Acutus Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations